<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Biogen is buying anti-inflammatory drug startup RayThera for up to $1 billion

The deal adds multiple small-molecule anti-inflammatory drug candidates to Biogen's pipeline, with the lead asset set to begin human trials this summer [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

qz
Biogen closes its $5.3 billion acquisition of Apellis Pharmaceuticals

Apellis, maker of eye disease drug SYFOVRE and kidney drug EMPAVELI, is now a wholly owned Biogen subsidiary [...]

Match Score: 55.74

qz
Novo Nordisk stock sinks after anti-inflammatory heart drug fails late-stage trial

The experimental anti-inflammatory drug ziltivekimab did not reduce major adverse cardiovascular events compared with a placebo in a study of more than 6,300 patients [...]

Match Score: 43.69

qz
Biogen stock sinks after Alzheimer's drug trial data fails to impress investors

The mid-stage study missed its primary goal, and the drug's lowest dose outperformed higher doses in ways the company cannot yet explain [...]

Match Score: 43.23

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 36.22

Destination
8 key drug patents expiring soon — and what it means for the market

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor en [...]

Match Score: 32.52

Destination
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices

Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]

Match Score: 32.52

venturebeat
Cerebras stock nearly doubles on day one as AI chipmaker hits $100 billion — what it means for AI infrastructure

Cerebras Systems, the Silicon Valley chipmaker that built the world's largest commercial AI processor, erupted onto the Nasdaq on Wednesday, opening at $350 per share — nearly double its $185 I [...]

Match Score: 32.02

Destination
For the Steam Machine to change PC gaming, Valve must solve Linux's anti-cheat problem

Following months of rumors, Valve finally announced the new Steam Machine earlier this week. And while I might question the company's decision to ship a system with only 8GB of VRAM in 2026, I be [...]

Match Score: 31.67

Destination
Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3

Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]

Match Score: 30.05